(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page

U.S.-China Tariff Increase Updates

by Jennifer P | May 21, 2019 | Canadian Regulatory, Cosmetics, Medical Devices, Research/Science/Technology, U.S. Regulatory

The Office of the United States Trade Representative (USTR) formally published a notice in the Federal Register on May 10th of an increase in tariffs from 10% to 25% on all List 3 products being imported from China. The 10% Tariff remains in effect until June 1st for...

Can Sunscreen Absorption into the Bloodstream Pose Health Risks?

by Jennifer P | May 9, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory

A pilot study recently published in the medical journal, JAMA, found that it took just one day of sunscreen use for several active ingredients in sunscreen products to enter the blood stream at high levels. The sunscreen absorption study, which was conducted by a...

Effects of Sterigenics Plant Shutdown on Medical Device Licences (MDL) in Canada

by Jennifer P | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory

Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...

Recent Posts

  • Interferon Beta 1a: Potentially Promising Treatment for Covid-19
  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?
  • New Canadian Cosmetic Ingredient Hotlist Updates

Recent Comments

    Archives

    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.